Practice guidelines: Conservative treatment of fibroids;Traitement conservateur des fibromes: Recommandations pour la pratique

Revue Medicale Suisse

Volumn 1, Issue 40, 2005, Pages 2591-2597

  Dubuisson, Jean Bernard ^a   Dubé, Marie Josée ^a   Stucki, David ^b   Hagmann, Peter Diego ^e   Hess, Thomas ^f   Hoogewoud, Henri Marcel ^c   Jacob, Sandrine ^a   Kinkel, Karen ⁱ   Mueller, Michael D ^g   Spörri, Stefan ^d   Steiner, Rolf ^h   Wenger, Jean Marie ^a  

^a HUG   (Switzerland)

^b Service de Gynécologie obstétrique   (Switzerland)

^c Spéc FMH Radiologie   (Switzerland)

^d Hopital Cantonal de Fribourg   (Switzerland)

^e Kantonsspital ^*  (Switzerland)

^f CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^g Clinique des Grangettes 7 ^*  (Switzerland)

^h KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

ⁱ Clinique des Grangettes   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; EPROSARTAN; IRBESARTAN; LOSARTAN; OLMESARTAN; POLYGLACTIN; TELMISARTAN; VALSARTAN;

ARTIFICIAL EMBOLISM; CLINICAL EXAMINATION; CONSERVATIVE TREATMENT; ENDOSCOPY; FEMALE INFERTILITY; HUMAN; HYSTERECTOMY; LAPAROSCOPY; MYOMECTOMY; PRACTICE GUIDELINE; REVIEW; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; UTERUS MYOMA; FEMALE; LEIOMYOMA; UTERUS CANCER;

FEMALE; HUMANS; LEIOMYOMA; PRACTICE GUIDELINES; UTERINE NEOPLASMS;

EID: 33644876291     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myomectomy for symptomatic uterine myomas. Fertility and Sterility 2005;83:1-23.
2. Steweard EA. Uterine Fibroids, The Lancet 2001; 357:293-8.
3. Benhaim Y, Ducarme G, Madelenat P, et al. The limits of laparoscopic myomectomy. Gynecol Obstet Fertil 2005;33:44-9.
4. Bulletti C, De Ziegler D, Levi Setti P, et al. Myomas, pregnancy outcome, and in vitro fertilization. Ann NY Acad Sci 2004;1034:84-92.
5. Dueholm M, Lundorf E, Hansen ES, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002;186: 409-15.
6. Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography in the differential diagnosis of adenomyoma versus leiomyoma. Am J Obstet Gynecol 1992; 167:603-6.
7. Togashi K, Ozasa H, Konishi I, et al. Enlarged uterus: Differenciation between adenomyosis and leiomyoma with MR imaging. Radiology 1989;171:531-4.
8. Tsushima Y, Kita T, Yamamoto K. Uterine lipoleiomyoma: MRI, CT and ultrasonographic findings. BR J Radiol 1997;70:1068-70.
9. Weinreb JC, Barkoff ND, Megibow A, et al. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. AJR 1990;154:295-9.
10. Friedman AJ, Rein MS, Harrison-Atlas D, et al. A randomized placebo contolled, double-blind study evalua-ting leuprolide acetate depot treatment before myomectomy. Fertil Steril 1989;52:728-33.
11. Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod 1999;14:44-8.
12. Vercellini P, Trespidi L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy:A controlled trial. Fertil Steril 2003; 79:1390-5.
13. Lethaby A, Vollenhoven B, Sowter M. Efficacy of preoperative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy:A systematic review. BJOG 2002;109:1097-108.
14. De Leo V, La Marca A, Morgante G. Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 1999;47:258-62.
15. De Leo V, Morgante G, La Marca A, et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drugs Saf 2002;25:759-79.
16. Eisinger SH, Meldrum S, Fiscella K, et al. Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol 2003;101:243-50.
17. Palomba S, Sammartino A, Di Carlo C, et al. Effects of raloxifene treatment on uterine leiomyomas in post-menopausal women. Fertil Steril 2001;76:38-43.
18. Palomba S, Orio F, Morelli M, et al. Raloxifene administration in premenopausal women with uterine leiomyomas: A pilot study. J Clin Endocrinol Metab 2002; 87:1502-8.
19. Fernandez H, Kadoch O, Capella-Allouc S, et al. Résection hystéroscopique des myomes sous muqueux: resultats à long terme. Ann Chir 2001;126:58-64.
20. Cravello L, Agostini A, Beerli M, et al. Résultats des myomectomies hystéroscopiques. Gynecol Obstet Fertil 2004;32:825-8.
21. Chapron C, Fernandez B, Fauconnier A, et al. Indications et modalités du traitement chirurgical conservateur des myomes interstitiels et sous-séreux. J Gynecol Obstet Biol Reprod 1999;28:732-37.
22. Seracchioli R, Colombo FM, Bagnoli A, et al. Laparoscopic myomectomy for fibroids penetrating the uterine cavity: Is it a safe procedure? BJOG 2003;110:236-40.
23. Nezhat C. The «cons» of laparoscopic myomectomy in women who may reproduce in the future. Int J Fertil Menopausal Stud 1996;41:280-83.
24. Dubuisson JB, Fauconnier A, Fourchette V, et al. Laparoscopic myomectomy: Predicting the risk of conversion to an open procedure. Hum Reprod 2001;16: 1726-31.
25. Dubuisson JB, Fauconnier A, Chapron C, et al. Second look after laparoscopic myomectomy. Hum Reprod 1998;13:2102-06.
26. Dessolle L, Soriano D, Poncelet C, et al. Determinants of pregnancy rate and obstetric outcome after laparoscopic myomectomy for infertility. Fertility and Sterility 2001;76:370-4.
27. Fauconnier A, Dubuisson JB,Ancel PY, et al. Prognostic factors of reproductive outcome after myomectomy in infertile patients. Hum Reprod 2000;15:1751-7.
28. Dubuisson JB, Fauconnier A, Deffarges JV, et al. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000;15:869-73.
29. Ribeiro SC, Reich H, Rosenberg J, et al. Laparoscopic myomectomy and pregnancy outcome in infertile patients. Fertility and Sterility 1999;71:571-4.
30. Roopnarinesingh S, Suratsingh J, Roopnarinesingh A. The obstetric outcome of patients with previous myomectomy or hysterotomy. West Indian Med J 1985;34: 59-62.
31. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995;346:671-2.
32. Report: Uterine Artery Embolization Survey: 10,500 procedures performed worlwide. Fairfax, VA: Society of Interventional Radiology, 2000.
33. Hovsepian DM, Siskin GP, Bonn J, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol 2004;27:307-13.
34. Marret H, Cottier JR Alonso AM, et al. Predictive factors for fibroids recurrence after uterine artery embolization. BJOG 2005;112:461-5.
35. Pron G, Mocarski E, Bennett J, et al. Ontario UFE Collaborative Group. Pregnancy after uterine artery embolization for leiomyomata:The Ontario Multicenter Trial. Obstet Gynecol 2005;105:67-76.
36. Woolf SH, Battista RN. Angerson GM, et al. Canadian Task Force on the Periodic Health Exam. Ottawa: Canada Communication Group; 1994;xxxvii.